Table 4.

Other anti-diabetic drugs that were used in the trials included in the meta-analysis and systematic review

Trials	Other anti-diabetic agents which were used	Duration of T2DM (years)
Araki et al. [7]	Empagliflozin + sulphonyl urea or metformin or thiazolidinedione or alpha-glucosidase inhibitor or glinide or dipeptidyl-peptidase-4	1 to ≥ 10
Ferrannini et al. [8]	Empagliflozin mono-therapy and empagliflozin + metformin	1 to ≥  5
Haring et al. [9]	Empagliflozin + metformin	1 to ≥  10
Kadowaki et al. [10]	Empagliflozin monotherapy	–
Roden et al. [11]	Empagliflozin monotherapy	1 to ≥  10
Softeland et al. [12]	Empagliflozin + linagliptin 5 mg and metformin	1 to ≥  10
Takkanen et al. [13]	Empagliflozin monotherapy	1 to ≥  10
Zinman et al. [14]	Empagliflozin + metformin and other anti-diabetic drugs (unspecified)	–

T2DM type 2 diabetes mellitus